A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Forlagets udgivne version, 1,16 MB, PDF-dokument
Originalsprog | Engelsk |
---|---|
Tidsskrift | Acta Neuropathologica |
Vol/bind | 138 |
Udgave nummer | 2 |
Sider (fra-til) | 237-250 |
Antal sider | 14 |
ISSN | 0001-6322 |
DOI | |
Status | Udgivet - 2019 |
Bibliografisk note
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. DOI: 10.1007/s00401-019-02026-8
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
Ingen data tilgængelig
ID: 225518896